Finding the best prices at pharmacies near you...


Cervical Cancer

Cervical Cancer

Cervical cancer is a type of cancer that occurs in the cervix, the lower part of the uterus connected to the vagina. The human papillomavirus (HPV) is a common cause of cervical cancer. It is usually diagnosed early on through a Pap test and is often successfully treated when caught early.

Symptoms of cervical cancer include vaginal bleeding after intercourse, between periods or after menopause, weight loss, back pain, appetite loss, fatigue, bone fractures, and pain during sexual intercourse. However, early-stage cervical cancer may be asymptomatic. 

Cervical cancer is usually treated with surgery to remove the uterus (hysterectomy), which can cure the condition and prevent the cancer returning. Radiation therapy and chemotherapy are also treatment options. 

Drug classes commonly used to treat cervical cancer include topoisomerase inhibitors to slow cancer cell growth and other cytotoxic antibiotics.

Products Related to Cervical Cancer:


Drugs Used To Treat Cervical Cancer:

Antineoplastic Monoclonal Antibodies
Commonly used to treat Brain Tumor, Cervical Cancer, Colon Cancer, Ovarian Cancer, Renal Cancer, colorectal cancer.
Camptothecin Analogs
Commonly used to treat Cervical Cancer, Ovarian Cancer.
Other Cytotoxic Antibiotics
Commonly used to treat penile cancer.
Camptothecin Analogs
Commonly used to treat Cervical Cancer, Ovarian Cancer.

Drugs Related to Cervical Cancer:

Antineoplastic Monoclonal Antibodies
Commonly used to treat Brain Tumor, Cervical Cancer, Colon Cancer, Ovarian Cancer, Renal Cancer, colorectal cancer.
Camptothecin Analogs
Commonly used to treat Cervical Cancer, Ovarian Cancer.
Other Cytotoxic Antibiotics
Commonly used to treat penile cancer.
Camptothecin Analogs
Commonly used to treat Cervical Cancer, Ovarian Cancer.

Blog Posts Related to Cervical Cancer:

HPV vaccine uptake among American adolescents ‘on the rise’

Nearly half (49 percent) of all adolescents aged between 13 and 17 were up-to-date with their human papillomavirus (HPV) vaccines in 2017, according to new data from the Centers for Disease Control and Prevention (CDC). The organization’s latest Morbidity and Mortality Weekly Report (MMWR)...

Read More

First biosimilar to cancer drug Neulasta approved by FDA

Fulphila (pegfilgrastim-jmdb) is the first biosimilar to Neulasta (pegfilgrastim) to gain approval from the US Food and Drug Administration (FDA). The Mylan GmbH medicine was approved as a treatment to reduce the risk of infection as suggested by febrile neutropenia (fever caused by a lack of...

Read More